Current Fluid Management Practice in Critically Ill Adults on Continuous Renal Replacement Therapy: A Binational, Observational Study
- PMID: 38626729
- PMCID: PMC11309063
- DOI: 10.1159/000538421
Current Fluid Management Practice in Critically Ill Adults on Continuous Renal Replacement Therapy: A Binational, Observational Study
Abstract
Introduction: In critically ill patients undergoing continuous renal replacement therapy (CRRT), a positive fluid balance (FB) is associated with adverse outcomes. However, current FB management practices in CRRT patients are poorly understood. We aimed to study FB and its components in British and Australian CRRT patients to inform future trials.
Methods: We obtained detailed electronic health record data on all fluid-related variables during CRRT and hourly FB for the first 7 days of treatment.
Results: We studied 1,616 patients from three tertiary intensive care units (ICUs) in two countries. After the start of CRRT, the mean cumulative FB became negative at 31 h and remained negative over 7 days to a mean nadir of -4.1 L (95% confidence interval (CI) of -4.6 to -3.5). The net ultrafiltration (NUF) rate was the dominant fluid variable (-67.7 mL/h; standard deviation (SD): 75.7); however, residual urine output (-34.7 mL/h; SD: 54.5), crystalloid administration (48.1 mL/h; SD: 44.6), and nutritional input (36.4 mL/h; SD: 29.7) significantly contributed to FB. Patients with a positive FB after 72 h of CRRT were more severely ill, required high-dose vasopressors, and had high lactate concentrations (5.0 mmol/L; interquartile range: 2.3-10.5). A positive FB was independently associated with increased hospital mortality (odds ratio: 1.70; 95% CI; p = 0.004).
Conclusion: In the study ICUs, most CRRT patients achieved a predominantly NUF-dependent negative FB. Patients with a positive FB at 72 h had greater illness severity and haemodynamic instability. Achieving equipoise for conducting trials that target a negative early FB in such patients may be difficult.
Keywords: Acute kidney injury; Critical illness; Fluid management; Renal replacement therapy; Water and electrolyte imbalance.
© 2024 The Author(s). Published by S. Karger AG, Basel.
Conflict of interest statement
The authors have no conflict of interest to declare.
Figures
Similar articles
-
Fluid removal associates with better outcomes in critically ill patients receiving continuous renal replacement therapy: a cohort study.Crit Care. 2020 Jun 1;24(1):279. doi: 10.1186/s13054-020-02986-4. Crit Care. 2020. PMID: 32487189 Free PMC article.
-
The interaction of net ultrafiltration rate with urine output and fluid balance after continuous renal replacement therapy initiation: A multi-Centre study.J Crit Care. 2024 Oct;83:154835. doi: 10.1016/j.jcrc.2024.154835. Epub 2024 May 20. J Crit Care. 2024. PMID: 38772126
-
How a positive fluid balance develops in acute kidney injury: A binational, observational study.J Crit Care. 2024 Aug;82:154809. doi: 10.1016/j.jcrc.2024.154809. Epub 2024 Apr 11. J Crit Care. 2024. PMID: 38609773
-
Fluid Management during Continuous Renal Replacement Therapy: A Case-Based Approach.Nephron. 2023;147(12):782-787. doi: 10.1159/000534395. Epub 2023 Oct 4. Nephron. 2023. PMID: 37793364 Review.
-
Fluid Balance in Continuous Renal Replacement Therapy: Prescribing, Delivering, and Review.Blood Purif. 2024;53(7):533-540. doi: 10.1159/000537928. Epub 2024 Feb 20. Blood Purif. 2024. PMID: 38377974 Review.
Cited by
-
Fluid balance neutralization secured by hemodynamic monitoring versus protocolized standard of care in patients with acute circulatory failure requiring continuous renal replacement therapy: results of the GO NEUTRAL randomized controlled trial.Intensive Care Med. 2024 Dec;50(12):2061-2072. doi: 10.1007/s00134-024-07676-1. Epub 2024 Oct 17. Intensive Care Med. 2024. PMID: 39417870 Free PMC article. Clinical Trial.
-
Ultrafiltration Tolerance and Improving Outcomes with Continuous Renal Replacement Therapies.Clin J Am Soc Nephrol. 2025 Mar 1;20(3):462-464. doi: 10.2215/CJN.0000000650. Epub 2024 Dec 26. Clin J Am Soc Nephrol. 2025. PMID: 39724028 No abstract available.
References
-
- Tolwani A. Continuous renal-replacement therapy for acute kidney injury. N Engl J Med. 2012;367(26):2505–14. - PubMed
-
- STARRT-AKI InvestigatorsCanadian Critical Care Trials GroupAustralian and New Zealand Intensive Care Society Clinical Trials GroupUnited Kingdom Critical Care Research GroupCanadian Nephrology Trials NetworkIrish Critical Care Trials Group, et al. . Timing of initiation of renal-replacement therapy in acute kidney injury. N Engl J Med. 2020;383(3):240–51. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources